US to authorize Pfizer vaccine for ages 12-15 early next week

Approval would bolster US vaccine drive and help ease parents’ worries over kids’ exposure to virusThe US Food and Drug Administration is preparing to authorize the Pfizer/BioNTech Covid vaccine for adolescents between ages 12 and 15 years by early next week, the New York Times reported on Monday, citing federal officials familiar with the agency’s plans.An approval is highly anticipated after the drugmakers said in March that the vaccine had been found to be safe, effective and produced robust antibody responses in 12- to 15-year-olds in a clinical trial. Continue reading…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

This website is using cookies to improve the user-friendliness. You agree by using the website further. Privacy policy

Skip to content